28186-62-1 Usage
Description
Benzoic acid, 3-iodo-5-(trifluoromethyl)is a chemical compound with the formula C9H5F3IO2. It is a derivative of benzoic acid, containing a 3-iodo-5-(trifluoromethyl) substituent. Benzoic acid, 3-iodo-5-(trifluoromethyl)is known for its strong electrophilic and nucleophilic tendencies, making it a versatile reagent and building block in organic synthesis and pharmaceutical research.
Uses
Used in Organic Synthesis:
Benzoic acid, 3-iodo-5-(trifluoromethyl)is used as a reagent in organic synthesis for the preparation of various compounds. Its strong electrophilic and nucleophilic properties allow it to participate in a wide range of chemical reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, Benzoic acid, 3-iodo-5-(trifluoromethyl)serves as a building block for the synthesis of diverse pharmaceutical compounds. Its unique structural features and reactivity contribute to the development of new drugs with potential therapeutic applications.
It is important to handle Benzoic acid, 3-iodo-5-(trifluoromethyl)with care due to its potentially hazardous properties. Proper safety precautions, such as working in a well-ventilated area and using appropriate personal protective equipment, should be taken to minimize risks during its use in research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 28186-62-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,1,8 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 28186-62:
(7*2)+(6*8)+(5*1)+(4*8)+(3*6)+(2*6)+(1*2)=131
131 % 10 = 1
So 28186-62-1 is a valid CAS Registry Number.
28186-62-1Relevant articles and documents
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
-
, (2008/06/13)
The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents
-
, (2008/06/13)
Intermediates for preparing benzylthio-, benzylsulfinyl-, and benzylsylfonyl-benzoic acids, and method of lowering the blood lipid level in mammals employing said acids.
